期刊
WORLD JOURNAL OF CLINICAL CASES
卷 7, 期 2, 页码 171-190出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.12998/wjcc.v7.i2.171
关键词
Exosome; Biomarker; Cancer; Diagnosis; Prognosis
资金
- General Research Fund, Research Grants Council of Hong Kong [CUHK462713, 14102714, 14136416, 14171217]
- National Natural Science Foundation of China [8142730, 81672323]
- CUHK
BACKGROUND Exosomes are microvesicles, measuring 30-100 nm in diameter. They are widely distributed in body fluids, including blood, bile, urine and saliva. Cancer-derived exosomes carry a wide variety of DNA, RNA, proteins and lipids, and may serve as novel biomarkers in cancer. AIM To summarize the performance of exosomal biomarkers in cancer diagnosis and prognosis. METHODS Relevant publications in the literature were identified by search of the PubMed database up to September 11, 2018. The quality of the included studies was assessed by QUADAS-2 and REMARK. For assessment of diagnostic biomarkers, 47 biomarkers and 2240 patients from 30 studies were included. RESULTS Our results suggested that these exosomal biomarkers had excellent diagnostic ability in various types of cancer, with good sensitivity and specificity. For assessment of prognostic markers, 50 biomarkers and 4797 patients from 42 studies were included. We observed that exosomal biomarkers had prognostic values in overall survival, disease-free survival and recurrence-free survival. CONCLUSION Exosomes can function as potential biomarkers in cancer diagnosis and prognosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据